CD8A and metastasis: In a murine model of liver metastasis, the combination of Piezo 1 agonist with anti‐PD‐1 therapy significantly improves the immunotherapy response, as evidenced by elevated PD‐L1 levels and increased CD8+ T cell infiltration.